Cargando…
Alerting the immune system via stromal cells is central to the prevention of tumor growth
Anticancer immunotherapies are highly desired. Conversely, unwanted inflammatory or immune responses contribute to oncogenesis, tumor progression, and cancer-related death. For non-immunogenic therapies to inhibit tumor growth, they must promote, not prevent, the activation of anticancer immune resp...
Autor principal: | Issazadeh-Navikas, Shohreh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913691/ https://www.ncbi.nlm.nih.gov/pubmed/24501690 http://dx.doi.org/10.4161/onci.27091 |
Ejemplares similares
-
Emerging evidence of anti-tumor immune control in the central nervous system
por: Donson, Andrew M., et al.
Publicado: (2012) -
In situ immunization via non-surgical ablation to prevent local and distant tumor recurrence
por: Veenstra, Jesse J, et al.
Publicado: (2015) -
Tumor suppression by stromal TIMPs
por: Shimoda, Masayuki, et al.
Publicado: (2016) -
IL-17A is a central regulator of lung tumor growth
por: Reppert, Sarah, et al.
Publicado: (2012) -
CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)